Farrell Peter C's Form 4 filing

Resmed Inc (RMD) · filed Feb 23, 2024

Accession no.: 0001127602-24-006731
Filed: Feb 23, 2024
Trade date: May 3, 2023-Feb 22, 2024
Filing delay: 296 daysLate
Rule 10b5-1 plan: Not checked

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market sales total $4.99M. It was filed 296 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Farrell Peter CCIK 0001186102	Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
May 3, 2023	ResMed Common Stock	SSaleDisposed	−12,600	$237.17^F1	−$2,988,342	166,896	Direct
Feb 22, 2024	ResMed Common Stock	SSaleDisposed	−10,935	$182.66^F2	−$1,997,387.1	157,404	Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

This transaction was executed in multiple trades at prices ranging from $236.40 - $237.94. The price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

This transaction was executed in multiple trades at prices ranging from $182.41 - $183.07. The price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)